Ranpu Wu

Southeast University — China

Medicine · Health Sciences

8h-index185citations16works7.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(6), Lung Cancer Diagnosis and Treatment(6), Lung Cancer Treatments and Mutations(6), Gastric Cancer Management and Outcomes(3), Lung Cancer Research Studies(3)

Publications16 total

Lymph nodes metastatic burden as a prognosticator for advanced non-small cell lung cancer: a real-world study
Journal of Thoracic Disease·2025Open Access
Identifying patients who benefit more from perioperative immunotherapy combinations for resectable non-small cell lung cancer based on clinical and molecular characteristics: a meta-analysis of randomized clinical trials
Clinical & Translational Oncology·2024
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors
Translational Lung Cancer Research·2024· 8 citedOpen Access
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features
Asia-Pacific Journal of Clinical Oncology·2024· 5 citedOpen Access
ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages
Journal of Experimental & Clinical Cancer Research·2024· 33 citedOpen Access
Efficacy and Safety of Neoadjuvant, Adjuvant, and Perioperative Immune Checkpoint Inhibitors Single Agent or with Chemotherapy in Resectable NSCLC: Indirect Comparison and Clinicopathological Impact
2024· 1 citedOpen Access
Efficacy and safety of perioperative, neoadjuvant, or adjuvant immunotherapy alone or in combination with chemotherapy in early-stage non-small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials
Therapeutic Advances in Medical Oncology·2024· 3 citedOpen Access
Comparing the efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis
2023Open Access
Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement: case series and literature review
Anti-Cancer Drugs·2023· 3 cited
Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
Therapeutic Advances in Medical Oncology·2023· 14 citedOpen Access
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
BMC Medicine·2022· 28 citedOpen Access
Analysis of M6A associated lncRNAs in prognosis and immune response of NSCLC patients.
PubMed·2022· 1 citedOpen Access
A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
Frontiers in Oncology·2021· 9 citedOpen Access
Metastasis-associated fibroblasts: an emerging target for metastatic cancer
Biomarker Research·2021· 54 citedOpen Access
A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers
Journal of Thoracic Disease·2021· 11 citedOpen Access
A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia
Translational Lung Cancer Research·2020· 15 citedOpen Access

Frequent Co-authors

Hongbing Liu(11), Chuling Li(9), Zhaofeng Wang(9), Yong Song(7), Yunchang Meng(7), Yanzhuo Gong(6), Zimu Wang(5), Tangfeng Lv(5), Yimin Wang(5), Huijuan Li(5), Zhangxuan Chen(4), Qingfeng Zhang(4), Suhua Zhu(3), Hedong Han(3), Yong Song(3), Xinjing Li(3), Hongbing Liu(2), Ying Wu(2), Yingshui Yao(2), Jiaxin Liu(1)